Publications

Group, Parkinson Study, and RA Hauser. 2007. “Mixed Lineage Kinase Inhibitor CEP-1347 Fails to Delay Disability in Early Parkinson Disease.”. Neurology.

Zesiewicz, TA, CL Ward, RA Hauser, JL Salemi, S Siraj, MC Wilson, and KL Sullivan. 2007. “A Pilot, Double-Blind, Placebo-Controlled Trial of Pregabalin (lyrica) in the Treatment of Essential Tremor.”. Mov Disord.

Hauser, RA, O Rascol, AD Korczyn, Jon Stoessl, RL Watts, W Poewe, PP De Deyn, and AE Lang. 2007. “Ten-Year Follow-up of Parkinson’s Disease Patients Randomized to Initial Therapy With Ropinirole or Levodopa.”. Mov Disord.

Simonson, W, RA Hauser, and AH Shapira. 2007. “Role of the Pharmacist in the Effective Management of Wearing-off in Parkinson’s Disease.”. Ann Pharmacother.

Zesiewicz, TA, CL Ward, RA Hauser, JL Salemi, S Siraj, MC Wilson, and KL Sullivan. 2007. “Levodopa-Induced Dyskinesia in Parkinson’s Disease: Epidemiology, Etiology, and Treatment.”. Curr Neurol Neurosci Rep.

Zesiewicz, TA, CL Ward, and RA Hauser. 2007. “Tiagabine and Exacerbation of Essential Tremor.”. Mov Disord.

Zesiewicz, TA, A Patel-Larson, RA Hauser, and KL Sullivan. 2007. “Social Security Disability Insurance (SSDI) in Parkinson’s Disease.”. Disabil Rehabil.

Hauser, RA, and TA Zesiewicz. 2007. “Advances in the Pharmacologic Management of Early Parkinson’s Disease.”. Neurologist.

Seeberger, LC, and RA Hauser. 2007. “Optimizing Bioavailability in the Treatment of Parkinson’s Disease.”. Neuropharmacology.

Hauser, RA. 2007. “Early Treatment of Parkinson’s Disease: How and When Should Therapy Be Initiated?”. Therapeutic Spotlight.